Ansing, Junerie Jhean .
HRN: 16-21-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2025
CEFUROXIME 1.5GM (VIAL)
03/20/2025
03/21/2025
IV
1.5g
Q8hr
Sp CS + BTL
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes